NCT01453400已完成3 期
Onset of Action of a Fast Release Aspirin Tablet and Acetaminophen Caplet in Sore Throat Pain
适应症
干预措施
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- Bayer
- 入组人数
- 177
- 主要终点
- Time to meaningful pain relief from the Sore Throat Pain Intensity Scale (STPIS) 100 mm visual analog scale
研究概览
简要总结
This study is to evaluate the onset of relief provided by a single, oral dose of fast release aspirin 1000 mg compared to acetaminophen 1000 mg and placebo in subjects with sore throat pain.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Triple (Participant, Care Provider, Investigator)
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Healthy, ambulatory, male and female subjects ≥ 18 years of age
- •Presence of sore throat due to upper respiratory tract infection (URTI)
- •Onset of sore throat pain within six days of the screening period
- •Baseline sore throat pain intensity score ≥ 60 mm on the Sore Throat Pain Intensity Scale
- •Have a score ≥ 5 on the Tonsillopharyngitis Assessment
- •Female subjects of childbearing potential who are currently sexually active must be using a medically acceptable form of birth control for at least one month prior to screening (three months on oral contraceptives), e.g., oral or patch contraceptives, intrauterine device, Nuvaring, Depo-Provera, or double-barrier and have a negative pregnancy test at screening/treatment period. Female subjects of non-childbearing potential must be amenorrheic for at least two years or had a hysterectomy and/or bilateral oophorectomy.
- •Understand the pain rating assessments
排除标准
- •History of hypersensitivity to aspirin, salicylates, other nonsteroidal anti-inflammatory drugs, acetaminophen, opioid analgesics, and similar drugs
- •Use of any "cold medication" (i.e. decongestants, antihistamines, expectorants, antitussives) within four hours preceding administration of the investigational product
- •Use of any immediate release analgesic/antipyretic within four hours or use of any sustained release or long-acting analgesic/antipyretic within twelve hours preceding administration of the investigational product
- •Consumption of alcoholic beverages, or foods and beverages containing xanthines within two hours prior to administration of the investigational product
- •Use of any sore throat lozenges, sprays, cough drops, menthol-containing products within one hour preceding administration of the investigational product
- •Presence of cough that causes throat discomfort
- •Presence of mouth-breathing or any respiratory condition that, in the Investigator's judgment, could compromise breathing
- •Evidence of clinically significant hematological, renal, endocrine, pulmonary, gastrointestinal, cardiovascular, hepatic, psychiatric, neurologic diseases, or malignancies for which aspirin or acetaminophen is contraindicated
- •Relevant concomitant disease such as medically uncontrolled asthma (exercise induced asthma is permitted), chronic sinusitis or nasal structural abnormalities causing greater than fifty percent obstruction
- •History of gastrointestinal bleeding or perforation related to previous non-steroidal anti-inflammatory therapy.
- •Current or past history of a bleeding disorder
- •Self reported alcoholism or drug abuse within two years prior to screening or routine consumption of three or more alcohol containing beverages per day
- •Habituation to analgesic drugs or tranquilizers (i.e., routine use of five or more times per week for greater than three weeks)
- •Acute illness, local infection, or disease (other than URTI with pharyngeal infection) that can interfere with the conduct of the study
- •Current use of blood thinning (anticoagulant), low dose aspirin, or steroid drug
- •Has initiated treatment for depression within the past thirty days
- •Females who are pregnant or lactating
研究组 & 干预措施
Arm 1
Experimental
干预措施: Acetylsalicylic Acid (Aspirin, BAY1019036) + placebo (Drug)
Arm 2
Active Comparator
干预措施: Acetaminophen + placebo (Drug)
Arm 3
Placebo Comparator
干预措施: Placebo (Drug)
结局指标
主要结局
Time to meaningful pain relief from the Sore Throat Pain Intensity Scale (STPIS) 100 mm visual analog scale
时间窗: Up to two hours
次要结局
- Global assessment of the investigational product as a pain reliever by grading from 0 to 4 (from poor to excellent)(Two hours postdose or immediately before the intake of rescue medication)
- Time to first perceptible relief (defined as the time when the subject presses the first stopwatch)(Up to two hours)
- Time weighted sum of pain intensity differences (PID) scores over first hour(Up to one hour)
- Time weighted sum of pain intensity differences (PID) scores over 2 hours(Up to two hours)
- Percentage difference from baseline Sore Throat Pain Intensity Scale (STPIS) to STPIS at time of meaningful relief(Up to two hours)
研究者
相似试验
已完成
3 期
Evaluate Onset of Action of a Fast Release AspirinHealthy SubjectsNCT01420094Bayer510
终止
3 期
Efficacy of a Single Dose of Aspirin vs. Acetaminophen in Tension Type HeadacheHeadacheNCT01552798Bayer9
已完成
1 期
DS1040b/Aspirin Drug/Drug Interaction StudyAcute Ischemic StrokeNCT02071004Daiichi Sankyo18
终止
1 期
Safe and effective use of aspirin in intensive care patients.Infection - Other infectious diseasesInflammatory and Immune System - Other inflammatory or immune system disordersSepsisACTRN12611000649910Royal Melbourne Hospital135
尚未招募
不适用
Effect of early administration of low dose aspirin therapy in obese pregnant women on miscarriage rate and uterine artery Doppler indices .PACTR201710002653297CUH400